189 related articles for article (PubMed ID: 3214942)
1. Effects of thyroid hormones (T4,T3), bromocriptine and Triac on inappropriate TSH hypersecretion.
Salmela PI; Wide L; Juustila H; Ruokonen A
Clin Endocrinol (Oxf); 1988 May; 28(5):497-507. PubMed ID: 3214942
[TBL] [Abstract][Full Text] [Related]
2. Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature.
Spitz IM; Sheinfeld M; Glasser B; Hirsch HJ
Postgrad Med J; 1984 May; 60(703):328-35. PubMed ID: 6429655
[TBL] [Abstract][Full Text] [Related]
3. 3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance.
Kunitake JM; Hartman N; Henson LC; Lieberman J; Williams DE; Wong M; Hershman JM
J Clin Endocrinol Metab; 1989 Aug; 69(2):461-6. PubMed ID: 2753985
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone.
Dulgeroff AJ; Geffner ME; Koyal SN; Wong M; Hershman JM
J Clin Endocrinol Metab; 1992 Oct; 75(4):1071-5. PubMed ID: 1400873
[TBL] [Abstract][Full Text] [Related]
5. Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine.
Rösler A; Litvin Y; Hage C; Gross J; Cerasi E
J Clin Endocrinol Metab; 1982 Jan; 54(1):76-82. PubMed ID: 6798060
[TBL] [Abstract][Full Text] [Related]
6. Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-thyroxine therapy.
Hamon P; Bovier-Lapierre M; Robert M; Peynaud D; Pugeat M; Orgiazzi J
J Clin Endocrinol Metab; 1988 Nov; 67(5):1089-93. PubMed ID: 3182960
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".
Gershengorn MC; Weintraub BD
J Clin Invest; 1975 Sep; 56(3):633-42. PubMed ID: 1159077
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of bromocriptine administration for selective pituitary resistance to thyroid hormone.
Ohzeki T; Hanaki K; Motozumi H; Ohtahara H; Ishitani N; Urashima H; Tsukuda T; Shiraki K; Sasaki S; Nakamura H
Horm Res; 1993; 39(5-6):229-34. PubMed ID: 8314208
[TBL] [Abstract][Full Text] [Related]
9. Inappropriate thyrotrophin secretion, increased dopaminergic tone and preservation of the diurnal rhythm in serum TSH.
Magee B; Sheridan B; Scanlon MF; Atkinson AB
Clin Endocrinol (Oxf); 1986 Feb; 24(2):209-15. PubMed ID: 3085996
[TBL] [Abstract][Full Text] [Related]
10. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
Kamoi K; Mitsuma T; Sato H; Yokoyama M; Washiyama K; Tanaka R; Arai O; Takasu N; Yamada T
Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
[TBL] [Abstract][Full Text] [Related]
11. Hyperthyroidism due to inappropriate secretion of thyroid-stimulating hormone: diagnosis and management.
Hermus A; Ross H; van Liessum P; Naber A; Smals A; Kloppenborg P
Neth J Med; 1991 Jun; 38(5-6):193-8. PubMed ID: 1922591
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3'-triiodothyroacetic acid (TRIAC).
Beck-Peccoz P; Piscitelli G; Cattaneo MG; Faglia G
J Endocrinol Invest; 1983 Jun; 6(3):217-23. PubMed ID: 6619530
[No Abstract] [Full Text] [Related]
13. Bromocriptine therapy for hyperthyroidism due to increased thyrotropin secretion.
Takamatsu J; Mozai T; Kuma K
J Clin Endocrinol Metab; 1984 May; 58(5):934-6. PubMed ID: 6707194
[TBL] [Abstract][Full Text] [Related]
14. Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.
Ueda S; Takamatsu J; Fukata S; Tanaka K; Shimizu N; Sakata S; Yamaji T; Kuma K; Ohsawa N
Thyroid; 1996 Dec; 6(6):563-70. PubMed ID: 9001190
[TBL] [Abstract][Full Text] [Related]
15. 3,5,3'-Triiodothyroacetic acid minimizes the pituitary thyrotrophin secretion in patients on levo-thyroxine therapy after ablative therapy for differentiated thyroid carcinoma.
Mueller-Gaertner HW; Schneider C
Clin Endocrinol (Oxf); 1988 Apr; 28(4):345-51. PubMed ID: 3142712
[TBL] [Abstract][Full Text] [Related]
16. [Hyperthyroidism caused by inadequate TSH secretion].
Zass R; Steindor U; Wendel U
Monatsschr Kinderheilkd; 1993 Feb; 141(2):100-2. PubMed ID: 7681522
[TBL] [Abstract][Full Text] [Related]
17. Anti-iodothyronine autoantibodies in a girl with hyperthyroidism due to pituitary resistance to thyroid hormones.
Crinò A; Borrelli P; Salvatori R; Cortelazzi D; Roncoroni R; Beck-Peccoz P
J Endocrinol Invest; 1992 Feb; 15(2):113-20. PubMed ID: 1569286
[TBL] [Abstract][Full Text] [Related]
18. Peripheral resistance to thyroid hormone in an infant.
Kaplowitz PB; D'Ercole AJ; Utiger RD
J Clin Endocrinol Metab; 1981 Nov; 53(5):958-63. PubMed ID: 6793616
[TBL] [Abstract][Full Text] [Related]
19. Hyperthyroidism due to familial pituitary resistance to thyroid hormone: successful control with 3, 5, 3' triiodothyroacetic associated to propranolol.
Aguilar Diosdado M; Escobar-Jimenez L; Fernandez Soto ML; Garcia Curiel A; Escobar-Jimenez F
J Endocrinol Invest; 1991 Sep; 14(8):663-8. PubMed ID: 1774450
[TBL] [Abstract][Full Text] [Related]
20. A case of inappropriate non-neoplastic secretion of TSH treated with bromocriptine.
Yeğen C; Aktan AO; Saraç AM; Yalin R
Endocr Regul; 1993 Mar; 27(1):23-5. PubMed ID: 8003703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
